← Back to Search

Procedure

TheraClearX treatment for Acne

N/A

Waitlist Available

Research Sponsored by Ablon Skin Institute Research Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, day 7, day 14, day 21, day 28, day 35 and day 49 or end of study visit.

Awards & highlights

Study Summary

This trial will test a treatment for mild-moderate acne in teens & adults (ages 12-40). Participants will have 6 weekly treatments & follow-up 2 weeks later. Photos & questionnaires will be taken.

Eligible Conditions

Acne

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, day 7, day 14, day 21, day 28, day 35 and day 49 or end of study visit.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, day 7, day 14, day 21, day 28, day 35 and day 49 or end of study visit.

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, day 7, day 14, day 21, day 28, day 35 and day 49 or end of study visit. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in inflammatory lesion counts

Change in non-inflammatory lesion counts

Percentage/Proportion of subjects who achieve at least a one-grade reduction in the IGA Score

Secondary outcome measures

Favorable Analysis of the Acne Subject Satisfaction questionnaire

Favorable Analysis of the Subject Consumer Perception questionnaire

Improvement in Acne QoL questionnaire scores

+1 more

Other outcome measures

Improvement in the VISIA photography imaging of the left, right and front views of the face.

Investigator Tolerability Assessment (erythema, edema, dryness, scaling, hypopigmentation and hyperpigmentation)

Subject Tolerability Self-Assessment (itching, burning and stinging)

+1 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: TheraClearX treatmentExperimental Treatment1 Intervention

TheraClearX treatment of the facial area weekly for 6 sessions.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Ablon Skin Institute Research CenterLead Sponsor

6 Previous Clinical Trials

306 Total Patients Enrolled

Strata Skin SciencesUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this study currently recruiting participants?

"As per information on clinicaltrials.gov, this trial is no longer looking for participants to join at present. The study was first posted on May 9th 2023 while the latest update came through on September 15th 2023. Thankfully, there are still 40 other active trials which require volunteers now."

Answered by AI

Does this research encompass adults aged over seventy-five?

"This trial adheres to strict inclusion criteria, requiring that participants be aged 12-40 years."

Answered by AI

What selection criteria are being utilized to identify participants for this medical trial?

"This research is seeking 30 individuals aged 12 to 40 that currently suffer from acne. To be considered for participation, applicants must present at least 10 papules, pustules or nodules in addition to a minimum of 10 and maximum 100 open/closed comedones on their face during the baseline visit."

Answered by AI

What are the principal aims of this investigation?

"This clinical trial will measure the primary outcome of Change in non-inflammatory lesion counts over a Baseline to Day 49 or End of Study (EOS) visit time frame. Secondary outcomes include Improvement in Acne Self Assessment questionnaire scores, Favorable Analysis of the Acne Subject Satisfaction questionnaire and Favorable Analysis of the Subject Consumer Perception questionnaire. The scales used for all three questionnaires range from 0 (Very satisfied) to 5 (Very dissatisfied), 1 (Very Satisfied) to 5 (Very Dissatisfied), and 1 (Very Likely) to 5 (Very Unlikely). Lower response values at Day 49 or EOS indicate"

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Study Evaluating the Efficacy and Safety of TheraClearX on Mitigating Mild to Moderate Acne

2023. "Study Evaluating the Efficacy and Safety of TheraClearX on Mitigating Mild to Moderate Acne". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06043102.

All > Acne